Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease
- 28 February 2009
- journal article
- Published by Elsevier BV in Neuromuscular Disorders
- Vol. 19 (2), 113-117
- https://doi.org/10.1016/j.nmd.2008.11.007
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Recombinant human acid α-glucosidaseNeurology, 2007
- Chinese hamster ovary cell-derived recombinant human acid α-glucosidase in infantile-onset Pompe diseaseThe Journal of Pediatrics, 2006
- A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe diseaseThe Journal of Pediatrics, 2006
- The natural course of non–classic Pompe’s disease; a review of 225 published casesZeitschrift für Neurologie, 2005
- Disease severity in children and adults with Pompe disease related to age and disease durationNeurology, 2005
- The Natural Course of Infantile Pompe’s Disease: 20 Original Cases Compared With 133 Cases From the LiteraturePediatrics, 2003
- Recombinant human acid ??-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trialGenetics in Medicine, 2001
- Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counsellingEuropean Journal of Human Genetics, 1999
- Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the diseaseAmerican Journal of Medical Genetics, 1998
- The spectrum and diagnosis of acid maltase deficiencyNeurology, 1973